Artiklar med krav på offentlig åtkomst - Richard B KimLäs mer
Inte tillgängliga någonstans: 35
Drug transporters in drug efficacy and toxicity
MK DeGorter, CQ Xia, JJ Yang, RB Kim
Annual review of pharmacology and toxicology 52 (1), 249-273, 2012
Krav: Canadian Institutes of Health Research
Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban
IY Gong, RB Kim
Canadian Journal of Cardiology 29 (7), S24-S33, 2013
Krav: Canadian Institutes of Health Research
Blood− brain barrier transporters and response to CNS-active drugs
BL Urquhart, RB Kim
European journal of clinical pharmacology 65, 1063-1070, 2009
Krav: Canadian Institutes of Health Research
Induction of intestinal P‐glycoprotein by St John's wort reduces the oral bioavailability of talinolol
UI Schwarz, H Hanso, R Oertel, S Miehlke, E Kuhlisch, H Glaeser, M Hitzl, ...
Clinical Pharmacology & Therapeutics 81 (5), 669-678, 2007
Krav: German Research Foundation
HLADQA1*05 genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease
A Wilson, C Peel, Q Wang, AD Pananos, RB Kim
Alimentary pharmacology & therapeutics 51 (3), 356-363, 2020
Krav: Canadian Institutes of Health Research
Trimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis
A Wilson, C McLean, RB Kim
Current opinion in lipidology 27 (2), 148-154, 2016
Krav: Canadian Institutes of Health Research
Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms
HE Meyer zu Schwabedissen, RB Kim
Molecular pharmaceutics 6 (6), 1644-1661, 2009
Krav: Canadian Institutes of Health Research, German Research Foundation
Interpatient variation in rivaroxaban and apixaban plasma concentrations in routine care
M Gulilat, A Tang, SE Gryn, P Leong-Sit, AC Skanes, JE Alfonsi, ...
Canadian Journal of Cardiology 33 (8), 1036-1043, 2017
Krav: Canadian Institutes of Health Research
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients
WA Teft, E Winquist, AC Nichols, S Kuruvilla, S Richter, C Parker, ...
Oral Oncology 89, 72-78, 2019
Krav: Canadian Institutes of Health Research
The transfer of pravastatin in the dually perfused human placenta
J Zarek, MK DeGorter, A Lubetsky, RB Kim, CA Laskin, H Berger, G Koren
Placenta 34 (8), 719-721, 2013
Krav: Canadian Institutes of Health Research
Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts
IY Gong, WA Teft, J Ly, YH Chen, B Alicke, RB Kim, EF Choo
Breast cancer research and treatment 139, 61-69, 2013
Krav: Canadian Institutes of Health Research
Disposition of atorvastatin, rosuvastatin, and simvastatin in Oatp1b2‐/‐mice and intraindividual variability in human subjects
MK DeGorter, BL Urquhart, U Gradhand, RG Tirona, RB Kim
The Journal of Clinical Pharmacology 52 (11), 1689-1697, 2012
Krav: Canadian Institutes of Health Research
Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption
AS Goldberg, RG Tirona, LJ Asher, RB Kim, SHM Van Uum
Thyroid 23 (11), 1374-1378, 2013
Krav: Canadian Institutes of Health Research
The impact of obesity on the pharmacology of medications used for cardiovascular risk factor control
S Sankaralingam, RB Kim, RS Padwal
Canadian Journal of Cardiology 31 (2), 167-176, 2015
Krav: Canadian Institutes of Health Research
In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna
MJ Cutler, BL Urquhart, TJ Velenosi, HEM Schwabedissen, GK Dresser, ...
The Journal of Clinical Pharmacology 52 (4), 530-542, 2012
Krav: Canadian Institutes of Health Research
Is personalized medicine a dream or a reality?
BL Morse, RB Kim
Critical reviews in clinical laboratory sciences 52 (1), 1-11, 2015
Krav: US National Institutes of Health, Canadian Institutes of Health Research …
CYP3A4 activity is markedly lower in patients with Crohn's disease
A Wilson, RG Tirona, RB Kim
Inflammatory Bowel Diseases 23 (5), 804-813, 2017
Krav: Canadian Institutes of Health Research
Crohn’s disease is associated with decreased CYP3A4 and P-glycoprotein protein expression
A Wilson, BL Urquhart, T Ponich, N Chande, JC Gregor, M Beaton, ...
Molecular Pharmaceutics 16 (9), 4059-4064, 2019
Krav: Canadian Institutes of Health Research
Identification, expression, and functional characterization of full-length and splice variants of murine organic anion transporting polypeptide 1b2
HE Meyer Zu Schwabedissen, JA Ware, RG Tirona, RB Kim
Molecular Pharmaceutics 6 (6), 1790-1797, 2009
Krav: Canadian Institutes of Health Research, German Research Foundation
Differences in warfarin pharmacodynamics and predictors of response among three racial populations
M Ohara, Y Suzuki, S Shinohara, IY Gong, CL Schmerk, RG Tirona, ...
Clinical pharmacokinetics 58, 1077-1089, 2019
Krav: American Heart Association
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.